[Double blind test with NAB 365 and 2 other sympathicomimetics for the examination of pulmonary function and circulation parameters as well as sleep behavior].
D000420:Albuterol / Q000494:pharmacology; D000814:Aniline Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001775:Blood Circulation / Q000187:drug effects*; D001991:Bronchitis / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004361:Drug Tolerance; D004562:Electrocardiography; D004983:Ethanolamines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D012123:Pulmonary Ventilation / Q000187:drug effects*; D011674:Pulse / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D013726:Terbutaline / Q000494:pharmacology
D000814:Aniline Compounds; D004983:Ethanolamines; D013726:Terbutaline; D000420:Albuterol
Doppelblindstudie mit NAB 365 und zwei weiteren Sympathikomimetika zur Uberpüfung von Lungenfunktions-und Kreislaufparamentern sowie des Schlafverhaltens.